LONDON and RALEIGH, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces its President and CEO, David Zaccardelli, has won ‘Executive ...

David Zaccardelli, the President and CEO of Verona Pharma plc (NASDAQ: VRNA), has sold shares worth approximately $2.25 million, according to a recent SEC filing. The transactions, executed on October ...

David R. Ebsworth, a director at Verona Pharma plc (NASDAQ: VRNA), recently acquired 20,000 ordinary shares of the company, as disclosed in a recent SEC filing. The shares were purchased at a price of ...

David Zaccardelli, the President and CEO of Verona Pharma plc (NASDAQ: VRNA), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Zaccardelli sold a ...

LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the ...

Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors. Ebsworth’s role will be effective from December 1 when he will take over from Prof Clive Page, ...

Juventus head coach Igor Tudor may be ready to gamble on a front line of Dusan Vlahovic, Jonathan David and Kenan Yildiz, as the Croatian attempts to get the in-form Serbian into the team alongside ...